The election of Donald Trump as the 45th President of the United States, along with the retention of Republican majorities in the U.S. House and Senate, portend major changes for U.S. healthcare, including the repeal of the Affordable Care Act. What changes are ahead? Will millions of newly insured people become uninsured again? Will President Trump improve healthcare affordability? In their new book, healthcare thought leaders Harry Nelson and Rob Fuller take on the big questions about healthcare on many people’s minds – not just what the repeal of ObamaCare will mean for patients and the healthcare industry, but what its replacement – TrumpCare – will look like.  What will the future hold for U.S. healthcare? What can we expect and what can we do to tackle healthcare challenges?  Nelson and Fuller get to the heart of the long-term challenges facing U.S. healthcare, the legacy of ObamaCare, and what to expect for healthcare under President Trump.

“Simply the most thoughtful and in-depth look at what might become the defining issue of the trump administration. a must read for anyone interested in the future of american healthcare.”

Josh Luke, Ph.D., University of Southern California Sol Price School of Public Policy

About the Authors

Harry Nelson is the founder and managing partner of Nelson Hardiman, a boutique healthcare law firm. For over two decades, he has been a problem-solver for the healthcare industry, focused on regulatory and reimbursement challenges and strategy. He speaks frequently about the future of U.S. healthcare, and sits on the boards of several healthcare organizations, including the American Addiction Treatment Association. Harry and his wife, Dorit, and their four children live in Los Angeles, California. You can follow Harry’s take on timely healthcare issues on Twitter at @nelsonh.

Rob Fuller, a partner in Nelson Hardiman, is an experienced attorney with a record of hands-on leadership in the healthcare industry. He ran an acute care hospital for over a decade, and has earned a reputation as an expert in healthcare operations. A Fellow of the American College of Healthcare Executives, Rob combines deep knowledge of the business and regulatory issues facing the healthcare and life sciences industries. Together with Harry, he co-chairs the investment committee of the Adaptive Healthcare Fund, which focuses on early stage health technology and healthcare turn-around opportunities.

A common sense guide that thoughtfully explains the context of the current debate . . . [m]uch needed clarity about confusing policy issues…”

Peter Boland, PhD, Managed Healthcare